Savient Pharmaceuticals will host Eighth Annual Equity Conference on Tuesday, January 17, 2012. The conference will be held at the Seminole Hard Rock Hotel in Hollywood, Florida. Among the eminent guests, Kenneth Zuerblis, Executive Vice President and Chief Financial Officer of Savient will also be present at the Noble Financial Capital Markets Eighth Annual Equity Conference.
A live webcast of the presentation can be accessed through the investor relations section of the Company’s website. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company aims at developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.
For further information, visit the link.
